Development an Immune-Related MicroRNA Risk Index in Hepatocellular Carcinoma.

Shun Zhou Jian Xu Dong Wang Yong Wang Lijuan Meng

Published in: Journal of oncology (2022)

We screened out five hub IRMs with clinical value and constructed a risk index model in HC, which can precisely assess the risk status and outcome of patients to a certain extent.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
wastewater treatment
patient reported outcomes